FocusDrug Development

The Host Battles Drug-Resistant Tuberculosis

Science Translational Medicine  19 Nov 2014:
Vol. 6, Issue 263, pp. 263fs47
DOI: 10.1126/scitranslmed.aaa1274

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

The repurposed drug metformin reduces unproductive inflammation, refocuses host immune responses on the infectious agent Mycobacterium tuberculosis, and thus may improve treatment outcomes for drug-resistant tuberculosis (Singhal et al., this issue).

View Full Text